GNH Community

Community, Nonprofits and Businesses sharing Information

Medicating Women’s Feelings - The Role of Anti-Anxiety Meds

Women’s emotionality is a sign of health, not disease; it is a source of power. But we are under constant pressure to restrain our emotional lives. We have been taught to apologize for our tears, to suppress our anger and to fear being called hysterical.

The pharmaceutical industry plays on that fear, targeting women in a barrage of advertising on daytime talk shows and in magazines. More Americans are on psychiatric medications than ever before, and in my experience they are staying on them far longer than was ever intended.  Sales of antidepressants and anti-anxiety meds have been booming in the past two decades, and they’ve recently been outpaced by an anti-psychotic, Abilify, that is the No. 1 seller among all drugs in the United States, not just psychiatric ones.

 As a psychiatrist practicing for 20 years, I must tell you, this is insane.

At least one in four women in America now takes a psychiatric medication, compared with one in seven men. Women are nearly twice as likely to receive a diagnosis of depression or anxiety disorder than men are. For many women, these drugs greatly improve their lives. But for others they aren’t necessary. The increase in prescriptions for psychiatric medications, often by doctors in other specialties, is creating a new normal, encouraging more women to seek chemical assistance. Whether a woman needs these drugs should be a medical decision, not a response to peer pressure and consumerism.

The new, medicated normal is at odds with women’s dynamic biology; brain and body chemicals are meant to be in flux. To simplify things, think of serotonin as the “it’s all good” brain chemical. Too high and you don’t care much about anything; too low and everything seems like a problem to be fixed.

The most common antidepressants, which are also used to treat anxiety, are selective serotonin reuptake inhibitors (S.S.R.I.s) that enhance serotonin transmission. S.S.R.I.s keep things “all good.” But too good is no good. More serotonin might lengthen your short fuse and quell your fears, but it also helps to numb you, physically and emotionally.

Obviously, there are situations where psychiatric medications are called for. The problem is too many genuinely ill people remain untreated, mostly because of socioeconomic factors. People who don’t really need these drugs are trying to medicate a normal reaction to an unnatural set of stressors: lives without nearly enough sleep, sunshine, nutrients, movement and eye contact, which is crucial to us as social primates.

 Medical chart reviews consistently show that doctors are more likely to give women psychiatric medications than men, especially women between the ages of 35 and 64. For some women in that age group the symptoms of perimenopause can sound a lot like depression, and tears are common. Crying isn’t just about sadness. When we are scared, or frustrated, when we see injustice, when we are deeply touched by the poignancy of humanity, we cry. And some women cry more easily than others. It doesn’t mean we’re weak or out of control. At higher doses, S.S.R.I.s make it difficult to cry. They can also promote apathy and indifference. Change comes from the discomfort and awareness that something is wrong; we know what’s right only when we feel it. If medicated means complacent, it helps no one.

http://www.nytimes.com/2015/03/01/opinion/sunday/medicating-womens-feelings.html?

Views: 60

Comment

You need to be a member of GNH Community to add comments!

Join GNH Community

Welcome (Bienvenido, Benvenuto, Powitanie, Bonjour! Willkomme,歡迎, ברוךהבא أهلا وسهلا, Bonvenon) to GNH Community. Traducción de esta página

Si no habla inglés, puede
leer el contenido de este sitio
web haciendo clic en
"Select language" arriba y
eligiendo "Spanish".
El contenido, excepto los
archivos adjuntos, aparecerán en español.

~

Non-English speaking residents can read the content of this website by clicking on "Select Language" above and picking their preferred language. Once a language is selected all content with the exception of attachments will appear in that language.

OPPORTUNITY + EQUITY

Imagine. Inform. Invest. Inspire. Working together to build a stronger community - now and forever.

The Community Foundation office at 70 Audubon Street is open to visitors by appointment only; Foundation staff are available by phone and email Monday through Friday from 8:30 a.m. - 5:00 p.m. to conduct business or to schedule a time to visit. To contact a staff member, view our staff directory.

 

 

 

Open Street Project

Local Initiatives Support Corporation

Laying the Cash Tracks for Community Impact

LISC CFO Christina Travers is among the impact investing leaders who contributed commentaries to a new book, The Social Justice Investor, and joined a panel discussion at today’s book launch. In her essay, “Laying the Cash Tracks,” (reprinted here) she explains the evolution of LISC’s capital markets experience—noting how discouraging Wall Street conversations eventually led to transformative, community-focused investments.

Sharing the Story of Social Justice Investing

With the launch of the new book, The Social Justice Investor, LISC’s Christina Travers reflects on the ways that CDFIs have tapped the capital markets to deepen their impact—working to upend lingering misconceptions among some investors. "Whether we are financing affordable housing, small businesses, health, safety, climate resilience, racial equity or jobs, we see financial performance and local impact as part of the same whole."

EPA Awards GRID Alternatives Solar for All Grant

LISC partner GRID Alternatives has been awarded a $249,800,000 Solar for All grant from the EPA to advance renewable and clean energy sources for affordable housing communities across the country. “The grant is an incredible boon to the movement to decarbonize homes and lower energy costs that burden millions of everyday Americans,” said Michael T. Pugh, president and CEO of LISC.

© 2024   Created by Lee Cruz.   Powered by

Badges  |  Report an Issue  |  Terms of Service